Europe’s Strong Interest in South Korea’s Pharmaceutical Innovation Confirmed in Basel!

On November 7, KPBMA International Cooperation Department and Basel Area Business & Innovation hosted a successful networking event in Basel, Switzerland, where global big pharma, biotech, and European life sciences professionals had the opportunity to engage with South Korea’s innovative pharmaceutical sector.

Hyunwoo Lee from KPBMA introduced South Korea’s pharmaceutical and biotech industries and emphasized KPBMA's commitment to actively supporting the European expansion of promising Korean companies.

Han Kim from Yuhan Corporation and Jaehong Park from Dong-A ST presented their remarkable pipelines and shared their strategies for future expansion into the European market.

The networking session that followed provided a dynamic platform for attendees to freely exchange ideas and discuss potential collaboration opportunities between Korean and European companies.

It was a meaningful time that confirmed the strong interest in South Korea’s pharmaceutical innovation, and we look forward to creating even more opportunities for collaboration in the future.

Find out more on LinkedIn : KPBMA International Cooperation Department